ScienceMag
The possibility that National Institute on Aging neuroscience chief Eliezer Masliah doctored images in scientific writings for decades is likely to provoke anxiety among multiple drug companies. The concerns recently documented in a dossier on more than 100 of his papers most directly challenge an experimental Parkinson’s disease therapy developed by Prothena (see main story…
Read More
Challenged papers underpin several drugs | Science
Tami Mcnaught
11:20
The possibility that National Institute on Aging neuroscience chief Eliezer Masliah doctored images in scientific writings for decades is likely to provoke anxiety among multiple drug companies. The concerns recently documented in a dossier on more than 100 of his papers most directly challenge an experimental Parkinson’s disease therapy developed by Prothena (see main story…
